Article
Effect of HMG-CoA reductase inhibitor on plasma cholesteryl ester transfer protein activity in primary hypercholesterolemia: comparison among CETP/TaqIB genotype subgroups.
Journal of atherosclerosis and thrombosis - 1 Jan 2002
Kotake Hidetoshi, Sekikawa Akihiro, Tokita Yoshihisa, Ishigaki Yasushi, Oikawa Shinichi
Abstract excerpt
We investigated the effects of HMG-CoA reductase inhibitors (statins) on the activity and concentration of plasma cholesterol ester transfer protein (CETP) in 30 hypercholesterolemic patients. Patients were divided into three groups according to TaqIB polymorphism of the CETP gene. The activity (158 +/- 23% control, mean +/- SEM) and concentration (4.1 +/- 1.0 mg/l) of plasma CETP were significantly (p < 0.005)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
